While the present study mainly focused on GPR84-mediated effector functions in macrophages, one should keep in mind that GPR84 activation has been associated with chemotaxis and oxidative bursts in neutrophils [17], which may constitute another interesting target for CRC therapy. The gene discussed is GPR84; the disease is colorectal carcinoma.